Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies.

Journal of clinical medicine·2026
Same author

Understanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China.

European journal of psychotraumatology·2026
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Clinical Evidence.

Journal of clinical medicine·2026
Same author

Effects of vaginal microbiota transfer on social-emotional and neurodevelopment in cesarean-born infants: 12-month follow-up of a pilot randomized clinical trial.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Self-perceived mental health among Canadian adolescents and young adults with asthma: Insights from a national cross-sectional study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Trends in Antipsychotic Drug Use in the United States, 2000-2016.

Pharmacy (Basel, Switzerland)·2026
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation.

Lihua An1, Karen Y Fung, Daniel Krewski

  • 1McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada. lihuaan@yahoo.com

Journal of Biopharmaceutical Statistics
|August 20, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method for analyzing drug safety data. The improved Bayesian logistic regression model enhances the detection of adverse drug reactions, particularly cardiovascular events associated with diabetic medications.

Related Experiment Videos

Last Updated: Jun 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Area of Science:

  • Pharmacovigilance and drug safety analysis.
  • Bayesian statistical modeling.
  • Cardiovascular risk assessment.

Background:

  • Spontaneous adverse event reporting systems are crucial for post-market drug surveillance.
  • Existing methods may have limitations in detecting subtle safety signals.
  • Identifying drug-induced cardiovascular events is a significant public health concern.

Purpose of the Study:

  • To develop and evaluate an advanced statistical strategy for analyzing pharmacovigilance data.
  • To improve the detection of adverse drug reactions using a Bayesian approach.
  • To investigate the association between diabetic drugs and cardiovascular event risk.

Main Methods:

  • Development of a James-Stein type shrinkage estimation strategy within a Bayesian logistic regression model.
  • Utilizing information pooling across medically related adverse events to enhance signal detection.
  • Computer simulations to compare the performance of the shrinkage estimator against the maximum likelihood estimator.
  • Application of the method to real-world pharmacovigilance data from the Canada Vigilance Online Database.

Main Results:

  • The developed shrinkage estimator demonstrated superior performance over the maximum likelihood estimator in terms of mean squared error.
  • The statistical method effectively combines information and borrows strength across related adverse events.
  • The analysis identified potential associations between certain diabetic drugs and an increased risk of cardiovascular events.

Conclusions:

  • The proposed James-Stein shrinkage estimation strategy offers a more robust and sensitive approach for analyzing pharmacovigilance data.
  • This Bayesian method enhances the ability to detect adverse drug event signals, contributing to improved drug safety monitoring.
  • Further investigation into the cardiovascular risks associated with specific diabetic medications is warranted based on these findings.